Alternatives to Kite Pharma
Kite Pharma is a Biotechnology tool: biotechnology company developing and commercializing cell therapies for cancer treatment. Here are the 56 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Kite Pharma
ImmunityBioNot ratedA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
- CRCrossbow TherapeuticsNot rated
Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.
ImmunoScapeNot ratedDeveloping novel immunotherapies and diagnostics for cancer.
Ella TherapeuticsNot ratedDeveloping microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
Immix Biopharma, Inc.Not ratedA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
Signadori BioNot ratedDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
Adaptimmune TherapeuticsNot ratedBiopharmaceutical company developing T-cell therapies for solid tumor cancers.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- EAEarendil LabsNot rated
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
CellaresNot ratedThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
STORM TherapeuticsNot ratedClinical-stage biotech company targeting RNA modifications for novel cancer therapies.
ONCOMATRYXNot ratedDeveloping Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
Showing the next 20 closest matches. See the rest on the Kite Pharma profile.
Sponsored rows are paid and labelled. Advertise on this page
